Cargando…

Acute Myeloid Leukemia With CEBPA Mutations: Current Progress and Future Directions

Mutations in CCAAT enhancer binding protein A gene (CEBPA) are one of the common genetic alterations in acute myeloid leukemia (AML). Recently, the emergence of new evidence makes it necessary to reconsider the subsets and treatment of AML patients with CEBPA mutations. This review will summarize th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Su, Long, Shi, Yuan-Yuan, Liu, Zeng-Yan, Gao, Su-Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8844020/ https://www.ncbi.nlm.nih.gov/pubmed/35178345 http://dx.doi.org/10.3389/fonc.2022.806137

Ejemplares similares

Prognostic Nomogram for Acute Myeloid Leukemia Patients With Biallelic CEBPA Mutations
por: Xu, Xiaoyu, et al.
Publicado: (2021)

Sporadic and Familial Acute Myeloid Leukemia with CEBPA Mutations
por: Yuan, Ji, et al.
Publicado: (2023)

Germline CEBPA mutation in familial acute myeloid leukemia
por: Boada, Matilde, et al.
Publicado: (2021)

CEBPA mutations in patients with de novo acute myeloid leukemia: data analysis in a Chinese population
por: Su, Long, et al.
Publicado: (2016)

Risk Stratification of Cytogenetically Normal Acute Myeloid Leukemia With Biallelic CEBPA Mutations Based on a Multi-Gene Panel and Nomogram Model
por: Wu, Li-Xin, et al.
Publicado: (2021)

Expression of CEBPA is reduced in RUNX1-mutated acute myeloid leukemia
por: Grossmann, V, et al.
Publicado: (2012)

Venetoclax-Based Combinations in Acute Myeloid Leukemia: Current Evidence and Future Directions
por: Samra, Bachar, et al.
Publicado: (2020)

Gain-of-Function Effects of N-Terminal CEBPA Mutations in Acute Myeloid Leukemia
por: Schmidt, Luisa, et al.
Publicado: (2020)

Two Novel CEBPA Mutations in a Turkish Patient with Acute Myeloid Leukemia
por: Tokgun, PE, et al.
Publicado: (2021)

Prognostic impact of CEBPA bZIP domain mutation in acute myeloid leukemia
por: Wakita, Satoshi, et al.
Publicado: (2022)

Acute myeloid leukemia due to germline CEBPA mutation in a Syrian family
por: Wafa, Abdulsamad, et al.
Publicado: (2022)

Mutational spectrum of acute myeloid leukemia patients with double CEBPA mutations based on next-generation sequencing and its prognostic significance
por: Su, Long, et al.
Publicado: (2018)

Clonal Evolution of Acute Myeloid Leukemia with CEBPA Double Mutations after Long-Term Remission: Case Report and a Literature Review
por: Li, Ying, et al.
Publicado: (2019)

Acute myeloid leukemia: current progress and future directions
por: Kantarjian, Hagop, et al.
Publicado: (2021)

Novel Mutations in CEBPA in Korean Patients with Acute Myeloid Leukemia with a Normal Karyotype
por: Kim, Sollip, et al.
Publicado: (2012)

In Silico Genetics Revealing 5 Mutations in CEBPA Gene Associated With Acute Myeloid Leukemia
por: Mustafa, Mujahed I, et al.
Publicado: (2019)

Mutational Landscape of CEBPA in Mexican Pediatric Acute Myeloid Leukemia Patients: Prognostic Implications
por: Molina Garay, Carolina, et al.
Publicado: (2022)

RUNX1/CEBPA Mutation in Acute Myeloid Leukemia Promotes Hypermethylation and Indicates for Demethylation Therapy
por: Romanova, Ekaterina I., et al.
Publicado: (2022)

Clinical Significance of bZIP In-Frame CEBPA-Mutated Normal Karyotype Acute Myeloid Leukemia
por: Ahn, Seo-Yeon, et al.
Publicado: (2023)

Characteristic immunophenotype and gene co-mutational status orchestrate to optimize the prognosis of CEBPA mutant acute myeloid leukemia
por: Chen, Xinjie, et al.
Publicado: (2023)

CAR T Cells for Acute Myeloid Leukemia: State of the Art and Future Directions
por: Mardiana, Sherly, et al.
Publicado: (2020)

CEBPA-regulated lncRNAs, new players in the study of acute myeloid leukemia
por: Hughes, James M, et al.
Publicado: (2014)

Research progress on molecular biomarkers of acute myeloid leukemia
por: Yin, Pei-Yuan, et al.
Publicado: (2023)

Transformation from acute promyelocytic leukemia to acute myeloid leukemia with a CEBPA double mutation: A case report and review of the literature
por: Sun, Ye, et al.
Publicado: (2021)

Identification and interrogation of the gene regulatory network of CEBPA-double mutant acute myeloid leukemia
por: Adamo, Assunta, et al.
Publicado: (2022)

Heterogeneity within AML with CEBPA mutations; only CEBPA double mutations, but not single CEBPA mutations are associated with favourable prognosis
por: Pabst, T, et al.
Publicado: (2009)

Prognostic implications of CEBPA mutations in pediatric acute myeloid leukemia: a report from the Japanese Pediatric Leukemia/Lymphoma Study Group
por: Matsuo, H, et al.
Publicado: (2014)

Haploidentical Stem Cell Transplantation for Acute Myeloid Leukemia: Current Therapies, Challenges and Future Prospective
por: Chang, Ying-Jun, et al.
Publicado: (2021)

Reply to ‘Heterogeneity within AML with CEBPA mutations; only CEBPA double mutations, but not single CEBPA mutations are associated with favorable prognosis’
por: Hou, H-A, et al.
Publicado: (2009)

Myeloid lineage enhancers drive oncogene synergy in CEBPA/CSF3R mutant acute myeloid leukemia
por: Braun, Theodore P., et al.
Publicado: (2019)

Targeting FLT3 Mutation in Acute Myeloid Leukemia: Current Strategies and Future Directions
por: Fedorov, Kateryna, et al.
Publicado: (2023)

Current Strategies and Future Directions to Achieve Deep Molecular Response and Treatment-Free Remission in Chronic Myeloid Leukemia
por: Annunziata, Mario, et al.
Publicado: (2020)

The ASXL1-G643Wvariant accelerates the development of CEBPA mutant acute myeloid leukemia
por: D’Altri, Teresa, et al.
Publicado: (2020)

Location, location, location: A mini-review of CEBPA variants in patients with acute myeloid leukemia
por: Faisal, Muhammad Salman, et al.
Publicado: (2023)

Therapeutic Antibodies for Myeloid Neoplasms—Current Developments and Future Directions
por: Schürch, Christian M.
Publicado: (2018)

The research progress of targeted therapy in acute myeloid leukemia based on bibliometric analysis
por: Huang, Wanxue, et al.
Publicado: (2022)

Characteristics of Cohesin Mutation in Acute Myeloid Leukemia and Its Clinical Significance
por: Han, Caixia, et al.
Publicado: (2021)

CD7 in acute myeloid leukemia: correlation with loss of wild-type CEBPA, consequence of epigenetic regulation
por: Röhrs, Sonja, et al.
Publicado: (2010)

Association between the CEBPA and c-MYC genes expression levels and acute myeloid leukemia pathogenesis and development
por: Krygier, Adrian, et al.
Publicado: (2020)

Runt-Related Transcription Factor 3 Promotes Acute Myeloid Leukemia Progression
por: Zhang, Wenwen, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_62fb5ttn07b32evb17l4fi1si8